Skip to main content
13079 search results for:

Alopecia 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 01-12-2024 | Myasthenia Gravis | OriginalPaper

    Taste disorders and alopecia in myasthenia gravis

    Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness with fatigue and mediated by autoantibodies against acetylcholine receptor (AChR) or muscle-specific tyrosine kinase (MuSK) [ 1 ]. Non-motor symptoms, such as pure red …

  2. 01-07-2024 | Alopecia Areata | Letter

    Bidirectional association between alopecia areata and prurigo nodularis: a population-based cohort study using TriNetX

  3. 11-03-2024 | Minoxidil | ReviewPaper

    Treatment Options for Alopecia Areata in Children and Adolescents

    Alopecia areata (AA) lifetime incidence is around 2%, with many patients first experiencing symptoms during childhood. However, ritlecitinib is the only FDA-approved treatment for pediatric patients 12 years and older. This review outlines …

  4. 01-12-2024 | Erbium YAG Laser | OriginalPaper

    Effectiveness and safety of the ablative fractional 2940-nm Er: YAG laser for the treatment of androgenetic alopecia

    Laser sources have established their potential effect in inducing hair regrowth. No large cohort study has evaluated the effect of ablative fractional 2940-nm erbium yttrium aluminum garnet (Er: YAG) laser in the treatment of androgenetic alopecia

  5. Open Access 01-12-2024 | Alopecia Areata | OriginalPaper

    Genetic links between atopy, allergy, and alopecia areata: insights from a Mendelian randomization study

    Alopecia areata (AA), an autoimmune disorder resulting in non-scarring hair loss, impacts about 2% of the global population [ 1 ], predominantly affecting individuals under 40 years, with a noticeable prevalence in Asian communities [ 2 ]. The …

  6. 01-07-2024 | Alopecia Areata | Letter

    Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study

  7. Open Access 16-04-2024 | Alopecia Areata | OriginalPaper

    The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016

    Alopecia areata (AA) is an autoimmune disease with an underlying immunoinflammatory pathogenesis [ 1 ]. AA presents as nonscarring hair loss ranging from small patches (alopecia focalis) to complete scalp (alopecia totalis [AT]) or scalp, face, and …

  8. 20-04-2024 | Alopecia | Online First

    Preventive effect of free radical scavenger edaravone lotion on cyclophosphamide chemotherapy-induced alopecia

    Chemotherapy-induced alopecia (CIA), a side effect occurring after the administration of cytotoxic anticancer drugs, significantly reduces the quality of life for patients with cancer [ 1 ]. Approximately half of the patients with cancer have …

  9. Open Access 31-03-2024 | Alopecia | OriginalPaper

    Utilising SNP Association Analysis as a Prospective Approach for Personalising Androgenetic Alopecia Treatment

    Androgenetic alopecia (AGA) represents the most common form of hair loss, affecting a significant proportion of both male and female populations. In men, it typically commences between adolescence and 30 years of age, with early onset indicating a …

  10. Open Access 01-12-2024 | Laser | ReviewPaper

    Lasers in the management of alopecia: a review of established therapies and advances in treatment

    Alopecia, also known as hair loss, is a highly prevalent condition affecting millions of men and women in the United States and worldwide, making it one of the most common complaints by patients presenting to a dermatologist. The symptomology on …

  11. Open Access 10-04-2024 | Calcineurin Inhibitors | OriginalPaper

    Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study

    Alopecia areata (AA) is an autoimmune disorder characterized by non-scarring hair loss that affects approximately 2% of the general population, including all ethnic, gender, and age groups [ 1 – 3 ]. The disease results in significant psychosocial …

  12. Open Access 29-03-2024 | Alopecia Areata | Online First

    Estimation of health utility values for alopecia areata

    Alopecia areata (AA) is an autoimmune-mediated inflammatory dermatological disease characterised by non-scarring hair loss, frequently involving the scalp but sometimes other hair-bearing sites, including eyebrows, eyelashes, facial and body hair …

  13. 01-05-2024 | Alopecia | Letter

    Characterization of alopecia clinical trials: an analysis of trials registered on clinicaltrials.gov

  14. Open Access 21-03-2024 | Alopecia Areata | Report

    Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries

    Alopecia areata (AA) is an autoimmune condition characterized by non-scarring hair loss, which can vary from small, well-defined patches to extensive, or even total, hair loss on the scalp, face, and/or body [ 1 ]. The lifetime incidence of AA is …

  15. Open Access 01-04-2024 | Cytostatic Therapy | OriginalPaper

    Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia

    This study was a single-institution review of outcomes from manual cold capping. The majority (65–80% or more) of those who undergo chemotherapy can expect some degree of chemotherapy-induced alopecia (CIA) [ 1 – 3 ]. Chemotherapy attacks rapidly …

  16. Open Access 01-12-2024 | Secondary Syphilis | OriginalPaper

    Secondary syphilis presenting with alopecia and leukoderma in a stable HIV-positive patient in a resource-limited setting: a case report

    Syphilis remains a public health threat, with an estimated seven million new cases in 2020 [ 1 ]. The disease burden is heavy in low- and middle-income countries, with a review of sexually transmitted infections (STIs) among pregnant women …

  17. 29-01-2024 | Stanolone | OriginalPaper

    Botulinum Toxin Type A Alleviates Androgenetic Alopecia by Inhibiting Apoptosis of Dermal Papilla Cells via Targeting circ_0135062/miR-506-3p/Bax Axis

    Botulinum toxin type A (BTXA) has the potential to treat androgenetic alopecia (AGA); however, its impact on the apoptosis of dermal papillary cells (DPCs) is not yet fully understood. Noncoding RNAs play a crucial role in AGA. In this study, we …

  18. Open Access 01-12-2024 | Laser | ReviewPaper

    The role of laser and energy-assisted drug delivery in the treatment of alopecia

    It has been recently established that laser treatment can be combined with topical or intralesional medications to enhance the delivery of drugs and improve overall results in a variety of different dermatological disorders. The aim of this review …

  19. 01-04-2024 | Minoxidil | Report

    Patient perspectives on topical minoxidil for hair loss: a survey-based study from the University of Michigan Alopecia Clinic

    Topical minoxidil is a widely used therapy for alopecia. Its availability over the counter in the United States makes it easily accessible. Various factors impact whether an individual decides to pursue treatment and/or continue long-term use. Our …

  20. 01-03-2024 | Alopecia | Letter

    Inflammatory proteomics analysis in different types of male androgenetic alopecia

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.